Abstract
Purpose of Review
As we know, psoriasis is the most prevalent chronic inflammatory skin condition due to aberrant immune response which is characterized by clearly demarcated red or pink thick raised skin plaques sometimes covered with dry thin silvery white scales, formed due to the cytokine-driven hyperproliferation of epidermal keratinocytes. The abnormal functioning of immune-inflammatory pathways can cause various systemic conditions including cardiovascular diseases, chronic renal disease, and metabolic syndrome.
Recent Findings
In comparison to other dermatological conditions, psoriasis has greater impact on the mental health of patients leading to increased risk of psychiatric comorbidities such as depression and anxiety. The Articial intellingence could automate the analysis and provide contextual relevance, enhance clinical reliability, assist the clinicians in communicating objectively, minimize human fatigue related errors, decrease mortality rates, save medical expenditures and help in easy and early diagnosis of diseases including psoriasis.
Summary
Therefore, development of better approaches for the diagnosis of psoriasis and determination of its classification type and severity are necessary for disease control and management and are the need of the hour. The artificial intelligence (AI) applications in medicine and healthcare are recently emerging due to advanced computing technologies and availability of abundant data on a variety of diseases including psoriasis. Hence, AI will certainly be a boon for the early detection and management of psoriasis patients necessitating further research in this area.
Similar content being viewed by others
Data Availability
This is to declare that all the data has been shared in the manuscript and there is no associated data.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Jiménez C, Bordagaray MJ, Villarroel JL, Flores T, Benadof D, Fernández A, et al. Biomarkers in oral fluids as diagnostic tool for psoriasis. Life (Basel). 2022;12(4):501. https://doi.org/10.3390/life12040501.
Skutnik-Radziszewska A, Maciejczyk M, Flisiak I, Kołodziej JKU, Kotowska-Rodziewicz A, Klimiuk A, et al. Enhanced inflammation and nitrosative stress in the saliva and plasma of patients with plaque psoriasis. J Clin Med. 2020;9(3):745. https://doi.org/10.3390/jcm9030745.
Tampa M, Sarbu MI, Mitran MI, Mitran CI, Matei C, Georgescu SR. The pathophysiological mechanisms and the quest for biomarkers in psoriasis, a stress-related skin disease. Dis Markers. 2018;28(2018):5823684. https://doi.org/10.1155/2018/5823684.
Davenport T, Kalakota R. The potential for artificial intelligence in healthcare. Future Healthc J. 2019;6(2):94–8. https://doi.org/10.7861/futurehosp.6-2-94.
Khan A, Sohail A, Zahoora U, Qureshi AS. A survey of the recent architectures of deep convolutional neural networks. Artif Intell Rev. 2020;53(8):5455–516. https://doi.org/10.1007/s10462-020-09825-6.
Secinaro S, Calandra D, Secinaro A, Muthurangu V, Biancone P. The role of artificial intelligence in healthcare: a structured literature review. BMC Med Inform Decis Mak. 2021;21(1):125. https://doi.org/10.1186/s12911-021-01488-9.
Pai VV, Pai RB. Artificial intelligence in dermatology and healthcare: an overview. Indian J Dermatol Venereol Leprol. 2021;87(4):457–467. https://doi.org/10.25259/IJDVL_518_19.
Shetty B, Fernandes R, Rodrigues AP, Chengoden R, Bhattacharya S, Lakshmanna K. Skin lesion classification of dermoscopic images using machine learning and convolutional neural network. Sci Rep. 2022;12(1):18134. https://doi.org/10.1038/s41598-022-22644-9.
Khan MA, Akram T, Zhang YD, Sharif M. Attributes based skin lesion detection and recognition: a mask RCNN and transfer learning-based deep learning framework. Pattern Recogn Lett. 2021;143:58–66.
Hossen MN, Panneerselvam V, Koundal D, Ahmed K, Bui FM, Ibrahim SM. Federated machine learning for detection of skin diseases and enhancement of internet of medical things (IoMT) security. IEEE J Biomed Health Inform. 2023;27(2):835–41. https://doi.org/10.1109/JBHI.2022.3149288.
• Yang Y, Wang J, Xie F, Liu J, Shu C, Wang Y, et al. A convolutional neural network trained with dermoscopic images of psoriasis performed on par with 230 dermatologists. Comput Biol Med. 2021;139:104924. https://doi.org/10.1016/j.compbiomed.2021.104924. This study described a CNN based on dermoscopic images as an efficient and accurate method to identify papulosquamous skin diseases.
Zhao S, Xie B, Li Y, Zhao X, Kuang Y, Su J, et al. Smart identification of psoriasis by images using convolutional neural networks: a case study in China. J Eur Acad Dermatol Venereol. 2020;34(3):518–24. https://doi.org/10.1111/jdv.15965.
• Aijaz SF, Khan SJ, Azim F, Shakeel CS, Hassan U. Deep Learning application for effective classification of different types of psoriasis. J Healthc Eng. 2022;15(2022):7541583. https://doi.org/10.1155/2022/7541583. This study demonstrated the potential of deep learning aproaches in accurate, reliable and effective classification of different psoriasis types and other skin diseases.
Pal A, Garain U, Chandra A, Chatterjee R, Senapati S. Psoriasis skin biopsy image segmentation using deep convolutional neural network. Comput Methods Programs Biomed. 2018;159:59–69. https://doi.org/10.1016/j.cmpb.2018.01.027.
Feldman SR, Krueger GG. Psoriasis assessment tools in clinical trials. Ann Rheum Dis. 2005;64(2):ii65–8ii69–73. https://doi.org/10.1136/ard.2004.031237.
Bożek A, Reich A. The reliability of three psoriasis assessment tools: psoriasis area and severity index, body surface area and physician global assessment. Adv Clin Exp Med. 2017;26(5):851–6. https://doi.org/10.17219/acem/69804.
Simpson MJ, Chow C, Morgenstern H, Luger TA, Ellis CN. Comparison of three methods for measuring psoriasis severity in clinical studies (part 2 of 2): use of quality of life to assess construct validity of the Lattice System Physician’s Global Assessment, Psoriasis Area and Severity Index and Static Physician’s Global Assessment. J Eur Acad Dermatol Venereol. 2015;29(7):1415–20. https://doi.org/10.1111/jdv.12861.
• Huang K, Wu X, Li Y, Lv C, Yan Y, Wu Z, et al. Artificial intelligence-based psoriasis severity assessment: real-world study and application. J Med Internet Res. 2023;16(25):e44932. https://doi.org/10.2196/44932. The authors proposed a valid image - artificial intelligence based model integrated into a mobile app for accurate severity assessment and long term self management of chronic disease in patients with psoriasis.
Schaap MJ, Cardozo NJ, Patel A, de Jong EMGJ, van Ginneken B, Seyger MMB. Image-based automated psoriasis area severity index scoring by convolutional neural networks. J Eur Acad Dermatol Venereol. 2022;36(1):68–75. https://doi.org/10.1111/jdv.17711.
Fink C, Alt C, Uhlmann L, Klose C, Enk A, Haenssle HA. Precision and reproducibility of automated computer-guided psoriasis area and severity index measurements in comparison with trained physicians. Br J Dermatol. 2019;180(2):390–6. https://doi.org/10.1111/bjd.17200.
Savolainen L, Kontinen J, Röning J, Oikarinen A. Application of machine vision to assess involved surface in patients with psoriasis. Br J Dermatol. 1997;137(3):395–400.
Lunge SB, Shetty NS, Sardesai VR, Karagaiah P, Yamauchi PS, Weinberg JM, et al. Therapeutic application of machine learning in psoriasis: a PRISMA systematic review. J Cosmet Dermatol. 2023;22(2):378–82. https://doi.org/10.1111/jocd.15122.
Meienberger N, Anzengruber F, Amruthalingam L, Christen R, Koller T, Maul JT, et al. Observer-independent assessment of psoriasis-affected area using machine learning. J Eur Acad Dermatol Venereol. 2020;34(6):1362–8. https://doi.org/10.1111/jdv.16002.
Amruthalingam L, Buerzle O, Gottfrois P, Jimenez AG, Roth A, Koller T, et al. Quantification of efflorescences in pustular psoriasis using deep learning. Healthc Inform Res. 2022;28(3):222–30. https://doi.org/10.4258/hir.2022.28.3.222.
Schleusener J, Guo S, Darvin ME, Thiede G, Chernavskaia O, Knorr F, et al. Fiber-based SORS-SERDS system and chemometrics for the diagnostics and therapy monitoring of psoriasis inflammatory disease in vivo. Biomed Opt Express. 2021;12(2):1123–35. https://doi.org/10.1364/BOE.413922.PMID:33680562;PMCID:PMC7901339.
• Okamoto T, Kawai M, Ogawa Y, Shimada S, Kawamura T. Artificial intelligence for the automated single-shot assessment of psoriasis severity. J Eur Acad Dermatol Venereol. 2022;36(12):2512–5. https://doi.org/10.1111/jdv.18354. This research proposed a rapid and simple tool associated with AI models for automated assessment of PASI scores from a single clinical image.
Acknowledgements
The authors are thankful to their respective institutes for providing the requisite platform to write this manuscript. The authors wish to thank Dr. Tej Khaket for reviewing their manuscript.
Funding
There was no funding received for the said work.
Author information
Authors and Affiliations
Contributions
RKS and MRS: Conceptualization, Data curation, writing original draft, Reviewing and Editing. AM, US, SS, SR: Data curation, analysis, Figure preparation, Reviewing and Editing; AKS: Conceptualization, Reviewing and Editing, Visualization, and Supervision.
Corresponding author
Ethics declarations
Ethical Approval
Not applicable.
Conflict of Interest
The authors declare no competing interests.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sharma, R.K., Sharma, M.R., Mahendra, A. et al. Artificial Intelligence Bringing Newer Paradigms in the Diagnosis, Treatment, and Management of Psoriasis. Curr Derm Rep 12, 314–320 (2023). https://doi.org/10.1007/s13671-023-00408-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13671-023-00408-6